The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - MSD, Novartis, AstraZeneca
Consulting or Advisory Role - MSD, BMS, Novartis
Phase 3 randomized trial (KEYNOTE-630) of adjuvant pembrolizumab (pembro) versus placebo (pbo) for high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) following surgery and radiation (RT).
 
Shlomo Koyfman
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Galera Therapeutics; Merck Sharp & Dohme; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Merck Sharp & Dohme (Inst)
Other Relationship - UpToDate
 
Jenny Lee
No Relationships to Disclose
 
Laurent Mortier
Honoraria - Bms france; MSD Oncology; Novartis; Sun pharma
Consulting or Advisory Role - BMS GmbH & Co. KG; Novartis; Sun Pharma
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech; Roche/Genentech
 
Åse Bratland
Honoraria - Bristol Myers Squibb; Merck Serono; MSD Oncology; Sanofi
Research Funding - Britol Myers Squibb (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Noel Luna-Romero
No Relationships to Disclose
 
Mitchell Chipman
No Relationships to Disclose
 
Marcin Dzienis
No Relationships to Disclose
 
Mikhail Klochikhin
No Relationships to Disclose
 
Jeremy Long
No Relationships to Disclose
 
Dmitry Kirtbaya
No Relationships to Disclose
 
Marcus Monroe
Consulting or Advisory Role - Merck; Regeneron
 
Markus Gifoni
Honoraria - AstraZeneca
Consulting or Advisory Role - Pfizer
Research Funding - Merck
 
John Kaczmar
Stock and Other Ownership Interests - HCA Healthcare (I)
Honoraria - The Scienomics Group; Triangle Insights Group
Consulting or Advisory Role - Coherus Biosciences; EMD Serono/Merck; PDS Biotechnology; Rakuten Medical
 
Jennifer DeSimone
Consulting or Advisory Role - Kyowa Kirin
Speakers' Bureau - Helsinn Therapeutics; Regeneron
Research Funding - Actelion; miRagen; Soligenix; Sun Pharma
 
Angela Zambrano
Travel, Accommodations, Expenses - Amgen; Roche
Other Relationship - MSD Oncology; Roche/Genentech
 
Cecile Pages Laurent
Travel, Accommodations, Expenses - Pierre Fabre
 
Juan Shen
No Relationships to Disclose
 
Jianda Yuan
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Burak Gumuscu
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Michael Schenker
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; BeiGene; BIOVEN; Bristol-Myers Squibb; Clovis Oncology; Daiichi Sankyo Europe GmbH; Eisai; Five Prime Therapeutics; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Mylan; Novartis; Pfizer/EMD Serono; PharmaMar; Regeneron; Roche; Samsung Healthcare; Sanofi/Regeneron; Tesaro
Travel, Accommodations, Expenses - Bristol Myers Squibb; Pfizer